
The month's biggest moves — from Pfizer and Blackstone's obesity co-funding agreement to Lilly's $3.5B Pennsylvania groundbreaking — answered in plain language.
Shire’s Second Act
almost 17 years ago
A Sturdy Frameworkalmost 17 years ago
Vaccines and Valuealmost 17 years ago
Tearing Up the Rule Bookalmost 17 years ago
Assets for Advantage





